Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
December 5th, 2020
Ovarian cancer stem cells (OCSC) are responsible for cancer initiation, recurrence, therapeutic resistance, and metastasis. The OCSC vascular niche is considered to promote self-renewal of OCSCs, leading to chemoresistance. This protocol provides the basis for establishing a reproducible OCSC vascular niche model in vitro.
Overview
This study investigates ovarian cancer stem cells (OCSC) and their vascular niche, emphasizing their role in cancer initiation and therapeutic resistance. The protocol establishes a reproducible in vitro OCSC vascular niche model that enables the analysis of tumor microenvironment remodeling.
Key Study Components
Research Area
- Ovarian cancer biology
- Cancer stem cell dynamics
- Vascular niche interactions
Background
- Ovarian cancer has high mortality rates among gynecological cancers.
- OCSCs contribute to tumor microenvironment remodeling.
- Previous models lacked reproducibility for detailed analysis.
Methods Used
- 3D co-culture system
- Human-derived cancer stem cells from ascites
- Density gradient centrifugation, light microscopy, and tube formation assays
Main Results
- The co-culture model enables observation of tumor initiation capabilities.
- Increased vascular tube formation was noted during OCSC co-culture.
- The system validated the angiogenic properties of OCSCs in tumor metastasis.
Conclusions
- The study provides insights into how OCSCs influence tumor angiogenesis.
- It highlights the relevance of 3D co-culture models in cancer research.
Frequently Asked Questions
Executive Industry Relevance
Reproducible 3D co-culture systems such as NICO-1 enable biopharma teams to interrogate the angiogenic properties of ovarian cancer stem-like cells (OCSCs) within a disease-relevant microenvironment. This approach supports predictive confidence in target validation and mechanistic de-risking at the tumor initiation and metastasis inflection points. The methodology enhances portfolio decision-making by clarifying the contribution of OCSCs to neovascularization and tumor progression.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of OCSC-driven angiogenesis in a controlled, reproducible system.
- Supports mechanistic de-risking by visualizing endothelial-OCSC interactions relevant to tumor initiation.
- Facilitates functional target validation for pathways implicated in tumor vascularization.
Screening & Assay Development
- Provides a validated 3D co-culture platform for quantitative tube formation assays.
- Enables standardization and reproducibility in evaluating angiogenic responses to OCSCs.
- Supports screening of compounds targeting OCSC-endothelial interactions in a scalable format.
Translational & Preclinical Research
- Aligns in vitro findings with disease-relevant mechanisms of metastasis and tumor microenvironment remodeling.
- Enables continuity from discovery-stage mechanistic studies to preclinical evaluation of anti-angiogenic strategies.
- Supports risk-adjusted advancement of candidates targeting OCSC-driven angiogenesis.
Pipeline & Workflow Integration
The NICO-1 3D co-culture system positions within the discovery-to-preclinical continuum, bridging early mechanistic studies and translational research on tumor angiogenesis.
- Discovery Biology: Facilitates hypothesis testing on OCSC contributions to neovascularization and tumor progression.
- Screening: Delivers reproducible, quantitative tube formation readouts for comparative analysis.
- Analytics: Enables measurement of vascular network formation and morphological changes over time.
- Translational Research: Provides a platform for evaluating disease-relevant angiogenic mechanisms in vitro.
- Enterprise Reuse: Offers a standardized, reusable system for ongoing target and pathway interrogation across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in angiogenesis-related target validation and mechanistic understanding.
- Operational Value: Enhances reproducibility and standardization of complex co-culture assays.
- Strategic Value: Informs go/no-go decisions for anti-angiogenic and tumor microenvironment-targeted therapies.
- Portfolio Impact: Supports risk-adjusted prioritization of candidates based on functional angiogenic outputs.
Implementation Considerations
- Requires expertise in 3D co-culture techniques and quantitative image analysis.
- Needs access to specialized culture devices (NICO-1) and imaging infrastructure.
- Demands cross-team standardization for assay setup and data interpretation.
- Adaptation may be needed for different cancer stem cell or endothelial cell sources.
- Limitations include in vitro modeling constraints and dependence on primary cell quality.
Biopharma FAQs
Chapters in this video
0:05
Introduction
0:55
Ovarian Cancer Stem Cell (OCSC) Isolation and Culture
2:23
CSC Passage
3:24
HUEhT-1 Endothelial Cell Culture
4:14
NICO-1 Coculture Plate Preparation
5:16
NICO-1 System HUEhT-1 and CSC Seeding
6:14
Results: Representative CSC-Induced Neovascularization and Vascular Formation
7:19
Conclusion
